Deepening on dreast cancer metastasis: The ERα-mediated modulation of KISS/KISS1R system

Endocrinology

Volumn 154, Issue 6, 2013, Pages 1959-1961

  González, Celestino ^a  

^a UNIVERSITY OF OVIEDO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR ALPHA; FOLLITROPIN; G PROTEIN COUPLED RECEPTOR 54; GELATINASE A; GELATINASE B; GONADORELIN; KISSPEPTIN; LUTEINIZING HORMONE; MATRIX METALLOPROTEINASE; PLASMIN; TISSUE INHIBITOR OF METALLOPROTEINASE; UROKINASE; G PROTEIN COUPLED RECEPTOR; KISS1R PROTEIN, HUMAN;

BREAST CANCER; BREAST CARCINOGENESIS; CANCER GROWTH; CANCER INHIBITION; COMPLEX FORMATION; HORMONE RELEASE; HUMAN; LOSS OF FUNCTION MUTATION; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SEXUAL INFANTILISM; SHORT SURVEY; TUMOR INVASION; ANIMAL; CELL MOTION; EPITHELIUM CELL; FEMALE; METABOLISM; NOTE;

ANIMALS; CELL MOVEMENT; EPITHELIAL CELLS; ESTROGEN RECEPTOR ALPHA; FEMALE; HUMANS; RECEPTORS, G-PROTEIN-COUPLED;

MLCS; MLOWN;

EID: 84878469390     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2013-1285     Document Type: Short Survey

References (35)

1. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69-90.
2. Greif JM. Mammographic screening for breast cancer: an invited review of the benefits and costs. Breast. 2010;19:268-272.
3. Samphao S, Wheeler AJ, Rafferty E, et al. Diagnosis of breast cancer in women age 40 and younger: delays in diagnosis result from underuse of genetic testing and breast imaging. Am J Surg. 2009;198:538-543.
4. Weigelt B, Peterse JL, van 't Veer LJ. Breast cancer metastasis: markers and models. Nat Rev Cancer. 2005;5:591-602. (Pubitemid 41081385)
5. Engers R, Gabbert HE. Mechanisms of tumor metastasis: cell biological aspects and clinical implications. J Cancer Res Clin Oncol. 2000;126:682-692.
6. Mareel M, Leroy A. Clinical, cellular, and molecular aspects of cancer invasion. Physiol Rev. 2003;83:337-376. (Pubitemid 36382891)
7. Siegel G, Malmsten M. The role of the endothelium in inflammation and tumor metastasis. Int J Microcirc. 1997;17:257-272. (Pubitemid 127793874)
8. Mareel MM, Bracke ME, Van Roy FM, et al. Molecular mechanisms of cancer invasion. Encycl Cancer. 1997;2:1072-1083.
9. Scott GK. Proteinases and proteinase inhibitors in tumour cell growth and metastasis. Cancer J. 1997;10:80-86. (Pubitemid 27234286)
10. Cvetkovic D, Dragan M, Leith SJ, et al. KIS1R induces invasiveness of estrogen receptor-negative human mammary epitelial an breast cancer cells [published online March 24, 2013]. Endocrinology. doi: 10.1210/en.2012-2164.
11. Lee JH, Miele ME, Hicks DJ, et al. KiSS-1, a novel human malignant melanoma metastasis-suppressor gene. J Natl Cancer Inst. 1996;88:1731-1737. (Pubitemid 26405010)
12. de Roux N, Genin E, Carel JC, et al. Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. Proc Natl Acad Sci USA. 2003;100:10972-10976. (Pubitemid 37140137)
13. Seminara SB, Messager S, Chatzidaki EE, et al. The GPR54 gene as a regulator of puberty. N Engl J Med. 2003;349:1614-1627. (Pubitemid 37303886)
14. Colledge WH. Kisspeptins and GnRH neuronal signalling. Trends Endocrinol Metab. 2009;20:115-121.
15. Ohta S, Lai EW, Pang AL, et al. Downregulation of metastasis suppressor genes in malignant pheochromocytoma. Int J Cancer. 2005;10:139-143. (Pubitemid 40194319)
16. Ikeguchi M, Yamaguchi K, Kaibara N. Clinical significance of the loss of KiSS-1 and orphan G-protein-coupled receptor (hOT7T175) gene expression in esophageal squamous cell carcinoma. Clin Cancer Res. 2004;10:1379-1383. (Pubitemid 38365232)
17. Sanchez-Carbayo M, Capodieci P, Cordon-Cardo C. Tumor suppressor role of KiSS-1 in bladder cancer: loss of KiSS-1 expression is associated with bladder cancer progression and clinical outcome. Am J Pathol. 2003;162:609-617. (Pubitemid 36267867)
18. Jiang Y, Berk M, Singh LS, et al. KiSS1 suppresses metastasis in human ovarian cancer via inhibition of protein kinase Cα. Clin Exp Metastasis. 2005;22:369-376. (Pubitemid 41609296)
19. Dhar DK, Naora H, Kubota H, et al. Downregulation of KiSS-1 expression is responsible for tumor invasion and worse prognosis in gastric carcinoma. Int J Cancer. 2004;111:868-872. (Pubitemid 39096235)
20. Masui T, Doi R, Mori T, et al. Metastin and its variant forms suppress migration of pancreatic cancer cells. Biochem Biophys Res Commun. 29004;315:82-92.
21. Lee JH, Welch DR. Identification of highly expressed genes in metastasis-suppressed chromosome 6/human malignant melanoma hybrid cells using subtractive hybridization and differential display. Int J Cancer. 1997;71:1035-1044. (Pubitemid 27252887)
22. Lee JH, Welch DR. Suppression of metastasis in human breast carcinoma MDA-MB-435 cells after transfection with the metastasis suppressor gene, KiSS-1. Cancer Res. 1997;57:2384-2387. (Pubitemid 27255895)
23. Martin TA, Watkins G, Jiang WG. KiSS-1 expression in human breast cancer. Clin Exp Metastasis. 2005;22:503-511. (Pubitemid 41750702)
24. Marot D, Bieche I, Aumas C, et al. 2007 High tumoral levels of Kiss1 and G-protein-coupled receptor 54 expression are correlated with poor prognosis of estrogen receptor-positive breast tumors. Endocr Relat Cancer. 2007;14:691-702. (Pubitemid 350074058)
25. Cho SG, Wang Y, Rodriguez M, et al. Haploinsufficiency in the prometastasis Kiss1 receptor Gpr54 delays breast tumor initiation, progression, and lung metastasis. Cancer Res. 2011;71:6535-6546.
26. Nomura H, Sato H, Seiki M, et al. Expression of membrane-type matrix metalloproteinase in human gastric carcinomas. Cancer Res. 1995;55:3263-3266.
27. Gao G, Liu L, Zou X, et al. Expression of KiSS-1, matrix metallo-proteinase-9, nuclear factor-κBp56 in ovarian tumor. Zhongua Fu Chan Ke Za Zhi. 2007;42:34-38.
28. Hou YK, Wang Y, Cong WM, et al. Expression of tumor metastasis-suppressor gene KiSS-1 and matrix metalloproteinase-9 in portal vein tumor thrombus of hepatocellular carcinoma. Ai Zheng. 2007;26:591-595.
29. Takino T, Koshikawa N, Miyamori H, et al. Cleavage of metastasis suppressor gene product KiSS-1 protein/metastin by matrix metalloproteinases. Oncogene. 2003;22:4617-4626. (Pubitemid 36976435)
30. Zajac M, Law J, Cvetkovic DD, et al. GPR54 (KISS1R) transactivates EGFR to promote breast cáncer cell invasiveness. PLoS One. 2011;6:e21599.
31. Clarke RB, Anderson E, Howell A. Steroid receptors in human breast cancer. Trends Endocrinol Metab. 2004;15 316-323. (Pubitemid 39180006)
32. Osborne CK. Tamoxifen in the treatment of breast cancer. N Engl J Med. 1998;339:1609-1618. (Pubitemid 28536137)
33. Paik S, Shak S, Tang G, et al. Amultigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med. 2004;351:2817-2826. (Pubitemid 40051905)
34. Paik S, Tang G, Shak S, et al. Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. J Clin Oncol. 2006;24:3726-3734. (Pubitemid 46622311)
35. Jansen MP, Foekens JA, van Staveren IL, et al. Molecular classification of tamoxifen-resistant breast carcinomas by gene expression profiling. J Clin Oncol. 2005;23:732-740. (Pubitemid 46224172)